Frontiers in Cardiovascular Medicine

Article	Citations
Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study	106
A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature	98
Arterial Stiffness and Hypertension in the Elderly	95
Hydrophilic or Lipophilic Statins?	88
Vascular Tissue Engineering: Polymers and Methodologies for Small Caliber Vascular Grafts	87
Hypertensive Disorders of Pregnancy and Future Cardiovascular Health	86
Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms	84
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management	81
Predicting Diagnostic Gene Biomarkers Associated With Immune Infiltration in Patients With Acute Myocardial Infarction	79
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus	78
Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution	74
Improving the Generalizability of Convolutional Neural Network-Based Segmentation on CMR Images	74
Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis	73
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae	72
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition	69
Evidence for Inflammation as a Driver of Atrial Fibrillation	69
The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population	67
The Role of the VEGF Family in Coronary Heart Disease	65
Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging	65
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players	64
Application of Machine Learning in Diagnosis of COVID-19 Through X-Ray and CT Images: A Scoping Review	64
Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited	63
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)	61
Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction	61
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms	59

SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity	58
Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis	57
Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis	57
Covid-19 Kills More Men Than Women: An Overview of Possible Reasons	56
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis	55
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT	54
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock	54
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis	53
A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021	53
Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases	52
COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies	52
Endothelial Cells in Emerging Viral Infections	51
Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview	50
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease	50
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases	50
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol	49
The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment	49
Procedure-Related Complications of Left Bundle Branch Pacing: A Single-Center Experience	48
CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction	47
Recent Development in Therapeutic Cardiac Patches	47
Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19	47
circSnx12 Is Involved in Ferroptosis During Heart Failure by Targeting miR-224-5p	47
The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies	46
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?	45
First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography	45
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study	44
miR-21 in Human Cardiomyopathies	43
Hemodynamic Relevance of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva-In Search of the Evidence	42
Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies	42
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy	42
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis	42
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs	41
Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity	41
Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles	40
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System	40
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines	40
Inflammation in Metabolic Cardiomyopathy	40
The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases	39
Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1	39
Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients	39
Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study	38
Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity	38
Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications	38
Hypertension and Drug Adherence in the Elderly	38
Diagnostic and Prognostic Biomarkers for Myocardial Infarction	38
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve	38
Telemedicine in Heart Failure During COVID-19: A Step Into the Future	37
Use of Multi-Modal Data and Machine Learning to Improve Cardiovascular Disease Care	37
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation	36
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model	36

The Role of Interleukin-6 Family Members in Cardiovascular Diseases	36
Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis	36
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection	36
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel	36
Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRA	36
Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability	35
Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity	35
Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population	35
Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis	35
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence	35
COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?	35
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors	34
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update	34
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review	34
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID	34
Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy	34
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis	34
Hypertension and COVID-19: Ongoing Controversies	34
Cardiomyocytes Cellular Phenotypes After Myocardial Infarction	34
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction	33
Antidepressant Drugs Effects on Blood Pressure	33
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients	32
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study	32
Endocan: A Key Player of Cardiovascular Disease	32
Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes	32
Radiomics Signatures of Cardiovascular Risk Factors in Cardiac MRI: Results From the UK Biobank	32
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review	32
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy	32
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation	32
Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure	31
Robotic Cardiac Surgery in Europe: Status 2020	31
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials	31
A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials	31
Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target	31
Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus	31
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation	31
Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis	31
Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis	31
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol	31
COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy	31
Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease	31
Gender-Related Differences in Heart Failure Biomarkers	31
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis	30
Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?	30
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer	30
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease	30
Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms	29
Evidence for the Benefits of Melatonin in Cardiovascular Disease	29
Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective	29
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers	29
SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock	29
Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries	29
Iron in Cardiovascular Disease: Challenges and Potentials	28
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype	28
Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020	28
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases	28
Deep Learning for Detecting and Locating Myocardial Infarction by Electrocardiogram: A Literature Review	28
Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem	28
Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review	28
Association Between Stress Hyperglycemia Ratio and In-hospital Outcomes in Elderly Patients With Acute Myocardial Infarction	28
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovas	28
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study	28
Mechanisms of Atherosclerosis Induced by Postprandial Lipemia	28
Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis	28
Electrocardiogram-Based Heart Age Estimation by a Deep Learning Model Provides More Information on the Incidence of Cardiovascular Disorders	28
Iron Deficiency: A New Target for Patients With Heart Failure	28
The Role of Artificial Intelligence in Cardiovascular Imaging: State of the Art Review	27
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity	27
Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction	27
Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies	27
Risk Factors for Anthracycline-Induced Cardiotoxicity	27
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases	27
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities	27
Machine Learning for Clinical Decision-Making: Challenges and Opportunities in Cardiovascular Imaging	27
Fairness in Cardiac Magnetic Resonance Imaging: Assessing Sex and Racial Bias in Deep Learning-Based Segmentation	27
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease	27
The Associations of Lipid Profiles With Cardiovascular Diseases and Death in a 10-Year Prospective Cohort Study	27
Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes	27
A Guide to Left Bundle Branch Area Pacing Using Stylet-Driven Pacing Leads	27
The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity	27

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study	27
The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications	27
Role of Exosomal miRNAs in Heart Failure	26
Update on Transcatheter Tricuspid Valve Replacement Therapies	26
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics	26
Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation	26
Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality	26
Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis	26
Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients	26
Partitioning the Right Ventricle Into 15 Segments and Decomposing Its Motion Using 3D Echocardiography-Based Models: The Updated ReVISION Method	26
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm	26
Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases	26
Cinematic Rendering in Mixed-Reality Holograms: A New 3D Preoperative Planning Tool in Pediatric Heart Surgery	26
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis	26
Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro	26
Left Bundle Branch Pacing: Current Knowledge and Future Prospects	26
NLRP3 inflammasome: The rising star in cardiovascular diseases	25
Radiation-Induced Vascular Disease—A State-of-the-Art Review	25
Association Between Triglyceride Glucose Index and Risk of New-Onset Diabetes Among Chinese Adults: Findings From the China Health and Retirement Longitudinal Study	25
Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study	25
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region	25
Wall shear stress and its role in atherosclerosis	25
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis	25
The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients	25
New Developments in Exosomal lncRNAs in Cardiovascular Diseases	25
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease	25
Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites	25
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances	25
The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications	25
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications	25
Roles of Ferroptosis in Cardiovascular Diseases	25
miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury	25
Cardiac Involvement in Recovered Patients From COVID-19: A Preliminary 6-Month Follow-Up Study	25
The Emerging Role of Neutrophil Extracellular Traps in Arterial, Venous and Cancer-Associated Thrombosis	25
Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype	25
Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases	25
Long-Term Clinical Outcomes in Patients With an Acute ST-Segment-Elevation Myocardial Infarction Stratified by Angiography-Derived Index of Microcirculatory Resistance	25
Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients	25
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System	25
Wnt Signaling in Vascular Calcification	24
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review	24
Feasibility and Outcomes of Upgrading to Left Bundle Branch Pacing in Patients With Pacing-Induced Cardiomyopathy and Infranodal Atrioventricular Block	24
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target	24
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination	24
Trends in Prevalence of Hypertension and Hypertension Phenotypes Among Chinese Children and Adolescents Over Two Decades (1991–2015)	24
Mini Review: Deep Learning for Atrial Segmentation From Late Gadolinium-Enhanced MRIs	24
Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities	24
Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients	24
Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI	24
Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction	24
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention	24
The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance	24
Smoking and the Pathophysiology of Peripheral Artery Disease	24
Obesity and Cardiovascular Disease: The Emerging Role of Inflammation	24
Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease	24
Which Biological Properties of Heart Valves Are Relevant to Tissue Engineering?	24
Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives	23
Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment	23
Territory-Wide Chinese Cohort of Long QT Syndrome: Random Survival Forest and Cox Analyses	23
Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021	23
Transcatheter Tricuspid Valve Intervention: Coaptation Devices	23
Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)	23
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis	23
Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19	23
Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis	23
Where the Action Is—Leukocyte Recruitment in Atherosclerosis	23
Electronic Cigarette Use and the Risk of Cardiovascular Diseases	23
Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients	23
Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger	23
Left Ventricular Myocardial Septal Pacing in Close Proximity to LBB Does Not Prolong the Duration of the Left Ventricular Lateral Wall Depolarization Compared to LBB Pacing	23
The Role of microRNAs in Heart Failure: A Systematic Review	23
Therapeutic Applications of Extracellular Vesicles for Myocardial Repair	23
Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease	23
Artificial intelligence in cardiology: Hope for the future and power for the present	22
Correlation Analysis of Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Frailty in Elderly Patients With Coronary Heart Disease	22
Sex–Gender Disparities in Cardiovascular Diseases: The Effects of Estrogen on eNOS, Lipid Profile, and NFATs During Catecholamine Stress	22
Abnormalities of Skeletal Muscle, Adipocyte Tissue, and Lipid Metabolism in Heart Failure: Practical Therapeutic Targets	22
Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts	22
The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders	22
Microvascular Angiopathic Consequences of COVID-19	22
Extraction of Coronary Atherosclerotic Plaques From Computed Tomography Imaging: A Review of Recent Methods	22
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward	22
Recent Advances in Biomechanical Characterization of Thoracic Aortic Aneurysms	22
Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke	22
Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World	22
NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease	22
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis	22
Environmental Risk Factors and Congenital Heart Disease: An Umbrella Review of 165 Systematic Reviews and Meta-Analyses With More Than 120 Million Participants	22
Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype	22
Studying the Endothelial Glycocalyx in vitro: What Is Missing?	22
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients	22
Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019	22
Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies	22
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial	22
Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance	22